Advertisement
Screener

Synergy CHC Corp. (SNYR) Scorecard

Synergy CHC Corp. (SNYR) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth No data; EPS growth No data.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
10/35 1.4 / 5 stars All 35 Win/Lose results and 85 gray no-data contests shown below

Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.

Trailing 1 year (4 quarters): 0 wins, 10 losses, 2 no dataLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/1 LoseSNYR / S&P
-84.57% / 15.20%
No dataSNYR / S&P
/ 15.00%
No dataSNYR / S&P
/ 50.40%
2026-Q10/3 LoseSNYR / S&P
-30.65% / -4.33%
LoseSNYR / S&P
-17.53% / 11.30%
LoseSNYR / S&P
-612.90% / 27.70%
2025-Q40/3 LoseSNYR / S&P
-23.77% / 2.65%
LoseSNYR / S&P
-12.78% / 9.00%
LoseSNYR / S&P
-534.48% / 13.40%
2025-Q30/3 LoseSNYR / S&P
-14.39% / 8.12%
LoseSNYR / S&P
-8.45% / 4.61%
LoseSNYR / S&P
-54.69% / 13.45%
2025-Q21/3 WinSNYR / S&P
21.28% / 10.94%
LoseSNYR / S&P
-18.71% / 4.83%
LoseSNYR / S&P
-44.29% / 10.63%
2025-Q10/1 LoseSNYR / S&P
-46.59% / -4.27%
No dataSNYR / S&P
/ 4.98%
No dataSNYR / S&P
/ 10.57%
2024-Q40/0 No dataSNYR / S&P
/ 2.41%
No dataSNYR / S&P
/ 5.25%
No dataSNYR / S&P
/ 6.15%
2024-Q30/0 No dataSNYR / S&P
/ 5.89%
No dataSNYR / S&P
/ 5.89%
No dataSNYR / S&P
/ 6.11%
2024-Q20/0 No dataSNYR / S&P
/ 4.28%
No dataSNYR / S&P
/ 5.38%
No dataSNYR / S&P
/ 5.12%
2024-Q10/0 No dataSNYR / S&P
/ 10.56%
No dataSNYR / S&P
/ 5.71%
No dataSNYR / S&P
/ 5.59%
2023-Q40/0 No dataSNYR / S&P
/ 11.69%
No dataSNYR / S&P
/ 6.81%
No dataSNYR / S&P
/ 7.78%
2023-Q30/0 No dataSNYR / S&P
/ -3.27%
No dataSNYR / S&P
/ 7.52%
No dataSNYR / S&P
/ -5.03%
2023-Q20/0 No dataSNYR / S&P
/ 8.74%
No dataSNYR / S&P
/ 9.50%
No dataSNYR / S&P
/ -8.57%
2023-Q10/0 No dataSNYR / S&P
/ 7.50%
No dataSNYR / S&P
/ 10.77%
No dataSNYR / S&P
/ -15.69%
2022-Q40/0 No dataSNYR / S&P
/ 7.56%
No dataSNYR / S&P
/ 11.88%
No dataSNYR / S&P
/ -17.99%
2022-Q30/0 No dataSNYR / S&P
/ -4.88%
No dataSNYR / S&P
/ 13.47%
No dataSNYR / S&P
/ -1.41%
2022-Q20/0 No dataSNYR / S&P
/ -16.10%
No dataSNYR / S&P
/ 13.71%
No dataSNYR / S&P
/ 11.04%
2022-Q10/0 No dataSNYR / S&P
/ -4.60%
No dataSNYR / S&P
/ 15.97%
No dataSNYR / S&P
/ 42.23%
2021-Q40/0 No dataSNYR / S&P
/ 11.03%
No dataSNYR / S&P
/ 15.00%
No dataSNYR / S&P
/ 96.40%
2021-Q30/0 No dataSNYR / S&P
/ 0.58%
No dataSNYR / S&P
/ 10.77%
No dataSNYR / S&P
/ 69.42%
2021-Q20/0 No dataSNYR / S&P
/ 8.55%
No dataSNYR / S&P
/ 6.58%
No dataSNYR / S&P
/ 51.81%
2021-Q10/0 No dataSNYR / S&P
/ 6.17%
No dataSNYR / S&P
/ -1.06%
No dataSNYR / S&P
/ 7.39%
2020-Q40/0 No dataSNYR / S&P
/ 12.15%
No dataSNYR / S&P
/ -3.72%
No dataSNYR / S&P
/ -33.42%
2020-Q30/0 No dataSNYR / S&P
/ 8.93%
No dataSNYR / S&P
/ -2.04%
No dataSNYR / S&P
/ -27.10%
2020-Q20/0 No dataSNYR / S&P
/ 20.54%
No dataSNYR / S&P
/ -0.46%
No dataSNYR / S&P
/ -27.11%
2020-Q11/2 No dataSNYR / S&P
/ -19.60%
LoseSNYR / S&P
-22.58% / 3.47%
WinSNYR / S&P
140.00% / -14.75%
2019-Q41/2 No dataSNYR / S&P
/ 9.07%
LoseSNYR / S&P
-13.21% / 5.36%
WinSNYR / S&P
42.86% / 2.99%
2019-Q31/2 No dataSNYR / S&P
/ 1.70%
LoseSNYR / S&P
-18.77% / 5.02%
WinSNYR / S&P
33.33% / 0.21%
2019-Q21/2 No dataSNYR / S&P
/ 4.30%
LoseSNYR / S&P
-13.51% / 6.64%
WinSNYR / S&P
33.33% / 8.65%
2019-Q11/2 No dataSNYR / S&P
/ 13.65%
LoseSNYR / S&P
-2.65% / 8.12%
WinSNYR / S&P
150.00% / 14.29%
2018-Q40/2 No dataSNYR / S&P
/ -13.52%
LoseSNYR / S&P
-4.98% / 9.05%
LoseSNYR / S&P
-800.00% / 18.23%
2018-Q30/1 No dataSNYR / S&P
/ 7.71%
LoseSNYR / S&P
-2.99% / 10.21%
No dataSNYR / S&P
/ 19.06%
2018-Q20/1 No dataSNYR / S&P
/ 3.43%
LoseSNYR / S&P
-9.08% / 9.03%
No dataSNYR / S&P
/ 14.46%
2018-Q10/1 No dataSNYR / S&P
/ -0.76%
LoseSNYR / S&P
-7.63% / 7.68%
No dataSNYR / S&P
/ 12.46%
2017-Q40/1 No dataSNYR / S&P
/ 6.64%
LoseSNYR / S&P
2.17% / 7.03%
No dataSNYR / S&P
/ 13.82%
2017-Q30/1 No dataSNYR / S&P
/ 4.48%
LoseSNYR / S&P
4.90% / 5.68%
No dataSNYR / S&P
/ 17.57%
2017-Q21/1 No dataSNYR / S&P
/ 3.09%
WinSNYR / S&P
48.04% / 4.83%
No dataSNYR / S&P
/ 17.74%
2017-Q11/1 No dataSNYR / S&P
/ 6.07%
WinSNYR / S&P
85.65% / 3.67%
No dataSNYR / S&P
/ 13.32%
2016-Q41/1 No dataSNYR / S&P
/ 3.82%
WinSNYR / S&P
158.91% / 2.09%
No dataSNYR / S&P
/ 7.05%
2016-Q31/1 No dataSNYR / S&P
/ 3.85%
WinSNYR / S&P
373.92% / 0.20%
No dataSNYR / S&P
/ -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricSNYR total returnS&P 500 Total Return Index
Total return-95.66%20.78%
Annualized return-95.66%20.78%

5Y · 2024-10-23 to 2026-08-27

MetricSNYR total returnS&P 500 Total Return Index
Total return-98.83%83.14%
Annualized return-58.94%12.86%

10Y · 2024-10-23 to 2026-08-27

MetricSNYR total returnS&P 500 Total Return Index
Total return-98.83%319.30%
Annualized return-35.92%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87